CLINICAL_TRIALS
trial_result
· 2021-06-04
Clinical Trial Update: Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer [Phase 4]
Summary
Phase 4 post-marketing study of rebamipide in patients with stomach ulcer has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Stomach Ulcer | Phase 4 | Status: COMPLETED | Results posted: 2021-06-04